Talk to your oncologist to see if molecular profiling is right for you in your cancer journey. If you are a good candidate for molecular profiling, a biopsy of your tumor will be sent to one of Sarah Cannon’s expert molecular profiling lab partners. They will analyze your tumor sample to find mutations in your tumor that might be driving your cancer. Once your oncologist receives the results, a personalized treatment plan – based on your tumor profile – will be generated.
With world class research physicians, who treat thousands of patients with different tumor types and have access to the latest molecular profiling technologies, Sarah Cannon is able to quickly determine the most effective treatment plans for patients, including identifying eligible patients for early and late-phase clinical trials.
Sarah Cannon has more than 100 molecularly-targeted clinical trials across its global network, giving patients access to the latest therapies specific to their cancer. Learn more about Sarah Cannon’s clinical trials.